IGC Stock Earnings: IGC Pharma Hits EPS and Beats Q4 2024 Revenues.

IGC Stock - IGC Stock Gains: IGC Pharma Meets EPS, Beats Q4 2024 Revenues.

Source: iQoncept / Shutterstock

IGC Pharma (NYSEMKT:IGC) just announced its fourth-quarter 2024 results.

IGC Pharma reported earnings per share of -4 cents. This was in line with analyst estimates for EPS of -4 cents.
The company saw revenue of $295,000.
This result was 55.26% ahead of analyst estimates for revenue of $190,000.

InvestorPlace Earnings is a project that uses data from TradeSmith to automate the preparation of quarterly earnings reports. InvestorPlace Earnings presents key findings including earnings per share and revenue, as well as company performance in line with analyst estimates. These articles are published without human intervention, allowing us to update our readers with the latest data as quickly as possible. To report any concerns or inaccuracies, please contact [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/06/igc-stock-earnings-igc-pharma-for-q4-of-2024/.